Cargando…

Discovery of Novel Small-Molecule Compounds with Selective Cytotoxicity for Burkitt’s Lymphoma Cells Using 3D Ligand-Based Virtual Screening

We describe a ligand-based approach towards compounds with more specific targeting for Burkitt’s lymphoma. Using three-dimensional ligand-based similarity searches and a previously described hit compound, we have identified six compounds that are chemically different but with similar spatial conform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gobec, Martina, Sosič, Izidor, Brus, Boris, Obreza, Aleš, Gobec, Stanislav, Mlinarič-Raščan, Irena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270761/ https://www.ncbi.nlm.nih.gov/pubmed/25415480 http://dx.doi.org/10.3390/molecules191119209

Ejemplares similares

Selective Cytotoxicity of Amidinopiperidine Based Compounds Towards Burkitt’s Lymphoma Cells Involves Proteasome Inhibition
por: Gobec, Martina, et al.
Publicado: (2012)

Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening
por: Scarpino, Andrea, et al.
Publicado: (2019)

Redox-Based Inactivation of Cysteine Cathepsins by Compounds Containing the 4-Aminophenol Moiety
por: Mirković, Bojana, et al.
Publicado: (2011)

Recent Advances in the Synthesis of Acylboranes and Their Widening Applicability
por: Šterman, Andrej, et al.
Publicado: (2020)

Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors
por: Schiffrer, Eva Shannon, et al.
Publicado: (2021)

Design and Synthesis of Novel N-Benzylidenesulfonohydrazide Inhibitors of MurC and MurD as Potential Antibacterial Agents
por: Frlan, Rok, et al.
Publicado: (2008)

A Putative Serine Protease is Required to Initiate the RIPK3-MLKL—Mediated Necroptotic Death Pathway in Neutrophils
por: Wang, Xiaoliang, et al.
Publicado: (2021)

The Binding Mode of Second-Generation Sulfonamide Inhibitors of MurD: Clues for Rational Design of Potent MurD Inhibitors
por: Simčič, Mihael, et al.
Publicado: (2012)

Combined Liquid Chromatography–Tandem Mass Spectrometry Analysis of Progesterone Metabolites
por: Sinreih, Maša, et al.
Publicado: (2015)

Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity
por: Mitrović, Ana, et al.
Publicado: (2019)

Psoralen Derivatives as Inhibitors of Mycobacterium tuberculosis Proteasome
por: Rožman, Kaja, et al.
Publicado: (2020)

Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
por: Milan Bonotto, Rafaela, et al.
Publicado: (2023)

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy
por: Nabergoj, Sanja, et al.
Publicado: (2018)

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
por: Mirković, Bojana, et al.
Publicado: (2015)

The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies
por: Markovič, Tijana, et al.
Publicado: (2022)

Development of an in-vivo active reversible butyrylcholinesterase inhibitor
por: Košak, Urban, et al.
Publicado: (2016)

Towards discovery of inhibitors of the undecaprenyl-pyrophosphate phosphatase BacA by virtual high-throughput screening
por: Jukič, Marko, et al.
Publicado: (2022)

Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads
por: Kollár, Levente, et al.
Publicado: (2021)

Burkitt Lymphoma: beyond discoveries
por: Mbulaiteye, Sam M
Publicado: (2013)

Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies
por: Proj, Matic, et al.
Publicado: (2022)

New Noncovalent Inhibitors of Penicillin-Binding Proteins from Penicillin-Resistant Bacteria
por: Turk, Samo, et al.
Publicado: (2011)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021)

Nep1-like proteins as a target for plant pathogen control
por: Pirc, Katja, et al.
Publicado: (2021)

Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo
por: Mitrović, Ana, et al.
Publicado: (2017)

Novel Selective IDO1 Inhibitors with Isoxazolo[5,4-d]pyrimidin-4(5H)-one Scaffold
por: Dolšak, Ana, et al.
Publicado: (2021)

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
por: Bagaloni, Irene, et al.
Publicado: (2021)

Synthesis of New Lipophilic Phosphonate and Phosphonamidate Analogues of N-Acetylmuramyl-L-alanyl-D-isoglutamine Related to LK 423
por: Gobec, Stanislav, et al.
Publicado: (2002)

Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview
por: Bolje, Aljoša, et al.
Publicado: (2021)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

Application of the N-Dibenzyl Protective Group in the Preparation of β-Lactam Pseudopeptides
por: Frlan, Rok, et al.
Publicado: (2019)

Synthesis of 3-Amino-4-substituted Monocyclic ß-Lactams—Important Structural Motifs in Medicinal Chemistry
por: Grabrijan, Katarina, et al.
Publicado: (2021)

Screening of Big Pharma’s Library against Various in-house Biological Targets
por: Knez, Damijan, et al.
Publicado: (2022)

Inhibition of MurA Enzyme from Escherichia coli by Flavonoids and Their Synthetic Analogues
por: Frlan, Rok, et al.
Publicado: (2023)

Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesis
por: Proj, Matic, et al.
Publicado: (2022)

A Double-Edged Kinase Lyn: A Positive and Negative Regulator for Antigen Receptor–mediated Signals
por: Nishizumi, Hirofumi, et al.
Publicado: (1998)

Bone Marrow Burkitt Lymphoma in a Child
por: Knežić, Matija, et al.
Publicado: (2020)

Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (–)-epicatechin
por: Rambaher, Martina Hrast, et al.
Publicado: (2023)

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022)

In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors
por: Zajec, Živa, et al.
Publicado: (2022)

Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
por: Loi, Elena M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gcjgn1k2b52cttjj39k0sqqsbg